Back
Regional Health Properties Vs. OptimizeRx Industry Stock Comparison
Sell
33
RHE
Regional Health Properties
Last Price:
1.62
Seasonality Move:
24.62%
Sell
22
OPRX
OptimizeRx
Last Price:
5.00
Seasonality Move:
11.57%
Sell
33
Regional Health Properties (RHE)
is a Sell
Is Regional Health Properties a Buy, Sell or Hold?
- The current Regional Health Properties [RHE] share price is $1.61. The Score for RHE is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- RHE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
OptimizeRx (OPRX)
is a Sell
Is OptimizeRx a Buy, Sell or Hold?
- The current OptimizeRx [OPRX] share price is $4.65. The Score for OPRX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- OPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RHE Stock Price Chart
What is Regional Health Properties's stock price today?
-
The Regional Health Properties share price today is $1.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RHE is experiencing slight buying pressure.
OPRX Stock Price Chart
What is OptimizeRx's stock price today?
-
The OptimizeRx share price today is $4.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPRX is experiencing selling pressure, which indicates risk of future bearish movement.
RHE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 47.76 | Sell |
| Chaikin Money Flow: | 1506 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.51 - 1.85) | Sell |
| Bollinger Bands (100): | (1.69 - 2.05) | Sell |
OPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 41.33 | Sell |
| Chaikin Money Flow: | -264270 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.52 - 6) | Sell |
| Bollinger Bands (100): | (5.83 - 9.51) | Sell |
RHE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.51 | Buy |
| 20-day SMA: | 1.64 | Sell |
| 50-day SMA: | 1.78 | Sell |
| 200-day SMA: | 2.21 | Sell |
| 8-day EMA: | 1.54 | Buy |
| 20-day EMA: | 1.62 | Sell |
| 50-day EMA: | 1.75 | Sell |
| 200-day EMA: | 2.08 | Sell |
OPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.32 | Buy |
| 20-day SMA: | 5.15 | Sell |
| 50-day SMA: | 6.26 | Sell |
| 200-day SMA: | 9.89 | Sell |
| 8-day EMA: | 4.68 | Sell |
| 20-day EMA: | 5.12 | Sell |
| 50-day EMA: | 6.1 | Sell |
| 200-day EMA: | 9 | Sell |
Regional Health Properties Earnings Growth & RHE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
OptimizeRx Earnings Growth & OPRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.07 per share.
Regional Health Properties Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
OptimizeRx Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||